Microdose follicular phase gonadotropin-releasing hormone agonists (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization 5

This publication has 21 references indexed in Scilit:

• Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis**Supported in part by grants from the National Research Council (CNR) of Italy (93.0286.04, 93.03409.11), and ASTO, Bologna, Italy.
  Fertility and Sterility, 1996
• Prospective study of short and ultrashort regimens of gonadotropin-releasing hormone agonist in an in vitro fertilization program
  Fertility and Sterility, 1992
• The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials
  Fertility and Sterility, 1992
• The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization
  Fertility and Sterility, 1992
• Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation: low-dose side effects in women and monkeys
  Fertility and Sterility, 1991
• Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization
  Fertility and Sterility, 1990
• Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval
  Fertility and Sterility, 1989
• Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization
  Fertility and Sterility, 1989
• Gonadotropin-Releasing Hormone Analog Design. Structure-Function Studies Toward the Development of Agonists and Antagonists: Rationale and Perspective
  Endocrine Reviews, 1986
• INDUCTION OF OVULATION FOR IN-VITRO FERTILISATION USING BUSERELIN AND GONADOTROPINS
  The Lancet, 1984